RNDr. Michal Cagalinec, PhD.
MC_pub_eng
Full CV List of publications |
||||
|
International grants: |
|
COST CA23156 European Network for Sigma-1 Receptor as a Therapeutic Opportunity (SIGMA-1EUROPE) (2024 – 2028) principal investigator (SK); principal investigator: Tangui Maurice |
|
ERA-CVD_JTC2019-055 HF-MetaB – Metabolic therapy of heart failure: which role for B vitamins (2020 – 2024) team member; principal investigator: Alexandra Zahradníková jr. |
|
Slovak Research and Development Agency (APVV): |
|
APVV-21-0473 Mutations associated with Wolfram syndrome: alternative signaling pathways for calcium and mitochondrial physiology (2022 – 2026) principal investigator |
|
APVV-21-0443 Mitochondrial disease in heart failure (2022 – 2026) team member; principal investigator: Alexandra Zahradníková jr. |
|
Grant Agency for Science (VEGA): |
|
VEGA 2/20182/21 Dyad remodelling in cardiomyocytes in experimental therapy of failing heart (2021 – 2024) team member; principal investigator: Alexandra Zahradníková jr. |